Clinical Trial Update: Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating carrimycin for safety and efficacy in hospitalized patients with COVID-19 has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• Carrimycin

Snippet

Sponsor: Shenyang Tonglian Group CO., Ltd | Conditions: Coronavirus Disease 2019 | Phase 3 | Status: TERMINATED